2004 Publications

Aaby, P; Jensen, H; Rodrigues, A; Garly, M.-, L; Benn, CS; Lisse, IM; Simondon, F; (2004) Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairs. International journal of epidemiology, 33 (2). pp. 367-73. ISSN 0300-5771 DOI: 10.1093/ije/dyh004

 

Aaby, P; Rodrigues, A; Biai, S; Martins, C; Veirum, JE; Benn, CS; Jensen, H; (2004) Oral polio vaccination and low case fatality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine, 22 (23-24). pp. 3014-3017. ISSN 0264-410X DOI:10.1016/j.vaccine.2004.02.009

 

Acosta, CJ; Galindo, CM; Deen, JL; Ochiai, RL; Lee, HJ; von Seidlein, L; Carbis, R; Clemens, JD; (2004) Vaccines against cholera, typhoid fever and shigellosis for developing countries. Expert opinion on biological therapy, 4 (12). pp. 1939-51. ISSN 1471-2598 DOI: 10.1517/14712598.4.12.1939

 

Armstrong, BG; Mangtani, P; Fletcher, A; Kovats, RS; McMichael, A; Pattenden, S; Wilkinson, P; (2004) Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people. BMJ (Clinical research ed), 329 (7467). p. 660. ISSN 0959-8138 DOI: 10.1136/bmj.38198.594109.AE

 

Batt, K; Fox-Rushby, JA; Castillo-Riquelme, M; (2004) The costs, effects and cost-effectiveness of strategies to increase coverage of routine immunizations in low- and middle-income countries: systematic review of the grey literature. Bulletin of the World Health Organization, 82 (9). pp. 689-96. ISSN 0042-9686

 

Breeze, E; Mangtani, P; Price, GM; Kovats, RS; Roberts, J; Fletcher, AE; (2004) Trends in influenza vaccination uptake among people aged over 74 years, 1997-2000: Survey of 73 general practices in Britain. BMC Fam Pract, 5 (1). p. 8. ISSN 1471-2296 DOI: 10.1186/1471-2296-5-8

 

Brinsmead, R; Hill, S; Walker, D; (2004) Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines. The Pediatric infectious disease journal, 23 (1). pp. 32-37. ISSN 0891-3668 DOI:10.1097/01.inf.0000105104.39284.a3

 

Brodin, P; Majlessi, L; Brosch, R; Smith, D; Bancroft, G; Clark, S; Williams, A; Leclerc, C; Cole, ST; (2004) Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. The Journal of infectious diseases, 190 (1). p. 115. ISSN 0022-1899 DOI:10.1086/421468

 

Connolly, MA; Gayer, M; Ryan, MJ; Salama, P; Spiegel, P; Heymann, DL; (2004) Communicable diseases in complex emergencies: impact and challenges. Lancet, 364 (9449). pp. 1974-83. ISSN 0140-6736 DOI: 10.1016/S0140-6736(04)17481-3

 

Craine, N; Walker, AM; Williamson, S; Brown, A; Hope, VD; (2004) Hepatitis B and hepatitis C seroprevalence and risk behaviour among community-recruited drug injectors in North West Wales. Communicable disease and public health / PHLS, 7 (3). pp. 216-9. ISSN 1462-1843

 

Cummins, A; Lane, L; Boccia, D; Crowcroft, NS; (2004) Survey of local immunisation training in England–the case for setting national standards. Communicable disease and public health / PHLS, 7 (4). pp. 267-71. ISSN 1462-1843

 

Cunha, SS; Dourado, I; Barreto, ML; Alexander, N; Pereira, SM; Ichihara, Y; Pereira, ES; Pedrosa, V; Maroja, F; Ribas, C;+1 more… (2004) Design of the Leprosy Component of the Brazilian BCG Revaccination Trial for Assessing BCG Effectiveness against Leprosy in School Children. International journal of leprosy and other mycobacterial diseases , 72 (1 ). 8-15. ISSN 0148-916X DOI: 10.1489/1544-581X(2004)072<0008:DOTLCO>2.0.CO;2

 

Cunha, SS; Rodrigues, LC; Pedrosa, V; Dourado, IM; Barreto, ML; Pereira, SM; (2004) Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon. Leprosy review, 75 (4). pp. 357-66. ISSN 0305-7518

 

Cutts, FT; Hall, AJ; (2004) Vaccines for neonatal viral infections: hepatitis B vaccine. Expert review of vaccines, 3 (4). pp. 349-52. ISSN 1476-0584 DOI: 10.1586/14760584.3.4.349

Fine, PE; (2004) Non-specific “non-effects” of vaccination – Literature does not support either beneficial or detrimental effects. BMJ (Clinical research ed), 329 (7478). pp. 1297-8. ISSN 0959-8138 DOI: 10.1136/bmj.329.7478.1297

 

Fine, PE; Oblapenko, G; Sutter, RW; (2004) Polio control after certification: major issues outstanding. Bulletin of the World Health Organization, 82 (1). pp. 47-52. ISSN 0042-9686

 

Fox-Rushby, JA; Kaddar, M; Levine, R; Brenzel, L; (2004) The economics of vaccination in low- and middle-income countries. Bulletin of the World Health Organization, 82 (9). p. 640. ISSN 0042-9686

 

French, N; Moore, M; Haikala, R; Kayhty, H; Gilks, CF; (2004) A case-control study to investigate serological correlates of clinical failure of 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults. The Journal of infectious diseases, 190 (4). pp. 707-12. ISSN 0022-1899 DOI: 10.1086/421911

 

Garmory, HS; Freeman, D; Brown, KA; Titball, RW; (2004) Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen. Vaccine, 22 (8). pp. 947-957. ISSN 0264-410X DOI:10.1016/j.vaccine.2003.09.020

 

Granerod, J; Davison, K; Stuart, J; Crowcroft, N; (2004) Clusters of meningococcal disease in educational establishments in the United Kingdom: April 2001 to March 2002. Communicable disease and public health / PHLS, 7 (1). pp. 51-5. ISSN 1462-1843

 

Griffiths, UK; Wolfson, LJ; Quddus, A; Younus, M; Hafiz, RA; (2004) Incremental cost-effectiveness of supplementary immunization activities to prevent neonatal tetanus in Pakistan. Bulletin of the World Health Organization, 82 (9). pp. 643-51. ISSN 0042-9686

 

Hahne, S; Ramsay, M; Balogun, K; Edmunds, WJ; Mortimer, P; (2004) Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy. Journal of clinical virology , 29 (4). pp. 211-20. ISSN 1386-6532 DOI: 10.1016/j.jcv.2003.09.016

 

Hall, A; (2004) Commentary: Vaccines and unexpected events. International journal of epidemiology, 33 (2). p. 381. ISSN 0300-5771 DOI: 10.1093/ije/dyh086

 

Hall, AJ; (2004) Vaccination and child mortality. Lancet, 364 (9452). pp. 2156-7. ISSN 0140-6736 DOI: 10.1016/S0140-6736(04)17604-6

 

Henderson, R; Oates, K; MacDonald, H; Smith, WC; Selvaraj, S; (2004) Factors influencing the uptake of childhood immunisation in rural areas. The British journal of general practice , 54 (499). pp. 114-8. ISSN 0960-1643

 

Kaljee, LM; Genberg, BL; von Seidlein, L; Canh, DG; Thoa le, TK; Thiem, VD; Tho le, H; Minh, TT; Trach, DD; (2004)Acceptability and accessibility of a Shigellosis vaccine in Nha Trang city of Viet Nam. Journal of health, population, and nutrition, 22 (2). pp. 150-8. ISSN 1606-0997

 

Khan, MM; Khan, SH; Walker, D; Fox-Rushby, J; Cutts, F; Akramuzzaman, SM; (2004) Cost of delivering child immunization services in urban Bangladesh: A study based on facility-level surveys. Journal of health, population, and nutrition, 22 (4). pp. 404-12. ISSN 1606-0997

 

Laine, C; Mwangi, T; Thompson, CM; Obiero, J; Lipsitch, M; Scott, JA; (2004) Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya. Infection and immunity, 72 (6). pp. 3331-5. ISSN 0019-9567 DOI: 10.1128/IAI.72.6.3331-3335.2004

 

Mangtani, P; Cumberland, P; Hodgson, CR; Roberts, JA; Cutts, FT; Hall, AJ; (2004) A cohort study of the effectiveness of influenza vaccine in older people, performed using the United kingdom general practice research database. The Journal of infectious diseases, 190 (1 ). 1-10 . ISSN 0022-1899 DOI: 10.1086/421274

 

Melegaro, A; Edmunds, WJ; (2004) The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses. European journal of epidemiology, 19 (4). pp. 353-63. ISSN 0393-2990

 

Melegaro, A; Edmunds, WJ; (2004) The 23-valent pneumococcal polysaccharide vaccine. Part II. A cost-effectiveness analysis for invasive disease in the elderly in England and Wales. European journal of epidemiology, 19 (4). pp. 365-75. ISSN 0393-2990

 

Melegaro, A; Edmunds, WJ; (2004) Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales. Vaccine, 22 (31-32). pp. 4203-14. ISSN 0264-410X DOI: 10.1016/j.vaccine.2004.05.003

 

Moorthy, VS; Imoukhuede, EB; Milligan, P; Bojang, K; Keating, S; Kaye, P; Pinder, M; Gilbert, SC; Walraven, G;Greenwood, BM; +1 more… (2004) A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults. PLoS medicine, 1 (2). e33. ISSN 1549-1277 DOI:10.1371/journal.pmed.0010033

 

Morgan, OW; (2004) Following in the footsteps of smallpox: can we achieve the global eradication of measles? BMC Int Health Hum Rights, 4 (1). p. 1. ISSN 1472-698X DOI: 10.1186/1472-698X-4-1

 

Morris-Cunnington, M; Edmunds, WJ; Miller, E; (2004) Immunity and exposure to hepatitis A virus in pre-adolescent children from a multi-ethnic inner city area. Communicable Disease and Public Health, 7 (2). pp. 134-7. Full text not available from this repository.

Morton, M; Garmory, HS; Perkins, SD; O’Dowd, AM; Griffin, KF; Turner, AK; Bennett, AM; Titball, RW; (2004) A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice. Vaccine, 22 (20). p. 2524. ISSN 0264-410X DOI: 10.1016/j.vaccine.2004.01.007

 

Mulholland, EK; (2004) Use of vaccine trials to estimate burden of disease. Journal of health, population, and nutrition, 22 (3). pp. 257-67. ISSN 1606-0997

 

Pinder, M; Reece, WH; Plebanski, M; Akinwunmi, P; Flanagan, KL; Lee, EA; Doherty, T; Milligan, P; Jaye, A; Tornieporth, N; +4 more… (2004) Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia. Clinical and experimental immunology, 135 (2). pp. 286-93. ISSN 0009-9104 DOI:10.1111/j.1365-2249.2004.02371.x

 

Polley, SD; McRobert, L; Sutherland, CJ; (2004) Vaccination for vivax malaria: targeting the invaders. Trends in parasitology, 20 (3). pp. 99-102. ISSN 1471-4922 DOI: 10.1016/j.pt.2003.12.003

 

Roth, A; Jensen, H; Garly, M.-, L; Djana, Q; Martins, CL; Sodemann, M; Rodrigues, A; Aaby, P; (2004) Low birth weight infants and Calmette-Guerin bacillus vaccination at birth: community study from Guinea-Bissau. The Pediatric infectious disease journal, 23 (6). pp. 544-550. ISSN 0891-3668 DOI: 10.1097/01.inf.0000129693.81082.a0

 

Roy, P; (2004) Genetically engineered structure-based vaccine for bluetongue disease. Veterinaria italiana, 40 (4). pp. 594-600. ISSN 0505-401X

 

Russell, FM; Mulholland, EK; (2004) Recent advances in pneumococcal vaccination of children. Annals of tropical paediatrics, 24 (4). pp. 283-94. ISSN 0272-4936 DOI: 10.1179/027249304225019109

 

Saito, M; Bautista, CT; Gilman, RH; Bowering, A; Levy, MZ; Evans, CA; (2004) The value of counting BCG scars for interpretation of tuberculin skin tests in a tuberculosis hyperendemic shantytown, Peru. The international journal of tuberculosis and lung disease , 8 (7). pp. 842-7. ISSN 1027-3719

 

Scott, S; Mossong, J; Moss, WJ; Cutts, FT; Kasolo, F; Sinkala, M; Cousens, S; (2004) Estimating the force of measles virus infection from hospitalised cases in Lusaka, Zambia. Vaccine, 23 (6). pp. 732-8. ISSN 0264-410X DOI:10.1016/j.vaccine.2004.07.026

 

Sexton, K; Lennon, D; Oster, P; Crengle, S; Martin, D; Mulholland, K; Percival, T; Reid, S; Stewart, J; O’Hallahan, J; (2004)The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic. The New Zealand medical journal, 117 (1200). U1015. ISSN 0028-8446

 

Smeeth, L; Cook, C; Fombonne, E; Heavey, L; Rodrigues, LC; Smith, PG; Hall, AJ; (2004) MMR vaccination and pervasive developmental disorders: a case-control study. Lancet, 364 (9438). pp. 963-9. ISSN 0140-6736 DOI:10.1016/S0140-6736(04)17020-7

 

Smeeth, L; Cook, C; Fombonne, PE; Heavey, L; Rodrigues, LC; Smith, PG; Hall, AJ; (2004) Rate of first recorded diagnosis of autism and other pervasive developmental disorders in United Kingdom general practice, 1988 to 2001. BMC Med, 2 (1). p. 39. ISSN 1741-7015 DOI: 10.1186/1741-7015-2-39

 

Smeeth, L; Thomas, SL; Hall, AJ; Hubbard, R; Farrington, P; Vallance, P; (2004) Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination. The New England journal of medicine, 351 (25). pp. 2611-2618. ISSN 0028-4793 DOI:10.1056/NEJMoa041747

 

Stevens, W; Walker, D; (2004) Adolescent vaccination in the developing world: time for serious consideration? Vaccine, 22 (5-6). pp. 781-785. ISSN 0264-410X DOI: 10.1016/j.vaccine.2003.05.001

 

Viviani, S; Mendy, M; Jack, AD; Hall, AJ; Montesano, R; Whittle, HC; (2004) EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia. Tropical medicine & international health , 9 (10). pp. 1044-1049. ISSN 1360-2276 DOI:10.1111/j.1365-3156.2004.01313.x

 

Walker, D; Mosqueira, NR; Penny, ME; Lanata, CF; Clark, AD; Sanderson, CF; Fox-Rushby, JA; (2004) Variation in the costs of delivering routine immunization services in Peru. Bulletin of the World Health Organization, 82 (9). pp. 676-82. ISSN 0042-9686

 

Watera, C; Nakiyingi, J; Miiro, G; Muwonge, R; Whitworth, JA; Gilks, CF; French, N; (2004) 23-Valent pneumococcal polysaccharide vaccine in HIV-infected Ugandan adults: 6-year follow-up of a clinical trial cohort. AIDS (London, England), 18 (8). pp. 1210-1213. ISSN 0269-9370 DOI: 10.1097/00002030-200405210-00018